| Project Title: | The Strategic of LongDaLi Co. Ltd |
| Author: | Mr. Li Dongliang |
| Advisor: | Associate Professor Li Chiao-Ming |
| Degree: | Master of Business Administration |
| Major: | Business Administration |
| Faculty: | Graduate Schools |
| Academic year: | 2017 |
Citation
Li, Dongliang. (2017). The strategic of LongDaLi Co. Ltd. (Independent study, Master of Business Administration). Bangkok: Siam University.
Abstract
Since the accession to WTO and the opening of China’s rapid growth of economy, the giant international corporations has been entering and seizing the Chinese market one after another in the form of sole investment and joint venture. The large domestic corporations of pharmaceutical intermediates also accelerated the integration of small and medium-sized enterprises, which directly resulted that the domestic market of pharmaceutical intermediates was becoming intenser and intenser. The biggest problem of intermediate corporations is how to meet challenges and how to make full use of their own advantages to expand the market. Therefore, formulating suitable strategy is the inevitable choice for the domestic corporations of pharmaceutical intermediates according to the development of internal and external environment and the capacity of resources.
This paper took the Shandong LongDaLi Co. Ltd (abbreviated as LDL) as the object and used the strategic management theory and tools to study the development strategy of LDL. Firstly, we used PEST Macro-environment and Baud’s Five Solid Model Analysis approach to study LDL’s external environment and to specify the opportunities and threats brought by its external environment. Secondly, we identified the advantages and disadvantages of LDL’s internal environment through analyzing its ability of production , research, market, manpower and finance. Thirdly, this paper established the SWOT Matrix of opportunities and threats from external environment, and advantages and disadvantages from internal environment with the theory of SWOT, and analyzed business with the Boston Matrix. Finally, we obtained the reasonable development strategy for LDL which was to use the differentiated competitive strategy and international competitive strategy on the basis of the total cost-preferment.
The results of this thesis not only served for the application of LDL, but also provided the important reference for the most Chinese intermediate corporations to make development strategy.
Keywords: LDL, Pharmaceutical Intermediates, Strategic Management, SWOT.
The Strategic of LongDaLi Co. Ltd
International Master in Business Administration (IMBA), Siam University, Bangkok, Thailand